T. Lynch

发表

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk

D. Christiani, R. Heist, J. Wain, 2008, Cancer Causes & Control.

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX‐710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

Bruce E. Johnson, T. Lynch, C. Langer, 2007, Cancer.

A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC): Final results

P. Jänne, N. Hanna, R. Govindan, 2005 .

Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.

D. Dias-Santagata, T. Lynch, H. Willers, 2008, Clinical lung cancer.

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.

D. Sugarbaker, T. Lynch, D. Harpole, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study

A. Wozniak, D. Spigel, J. Brahmer, 2016, Pharmacoepidemiology and drug safety.

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.

S. Digumarthy, A. Iafrate, L. Chirieac, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.

B. Rollins, T. Lynch, G. Shapiro, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

David N Louis, Ultan McDermott, Jeffrey W. Clark, 2010, EMBO molecular medicine.

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.

D. Haber, Sreenath V. Sharma, J. Settleman, 2005, Cold Spring Harbor symposia on quantitative biology.

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Alona Muzikansky, Thomas J Lynch, Bruce E Johnson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.

Jeffrey W. Clark, A. Fischman, G. Demetri, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Jeffrey W. Clark, A. Iafrate, P. Jänne, 2010, The New England journal of medicine.

Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial.

T. Lynch, I. Bondarenko, F. Barlesi, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Burnout: caring for the caregivers.

T. Lynch, F. Dignan, R. Penson, 2000, The oncologist.

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

W. Richards, D. Sugarbaker, T. Lynch, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.

D. Christiani, J. Wain, T. Lynch, 2001, Cancer research.

Communicating genetic risk: pros, cons, and counsel.

T. Lynch, B. Chabner, M. Seiden, 2000, The oncologist.

Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk.

D. Christiani, J. Wain, T. Lynch, 2001, Journal of the National Cancer Institute.

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

S. Digumarthy, A. Iafrate, C. Channick, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma

N. Nishioka, D. Christiani, R. Heist, 2008, British Journal of Cancer.

A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.

P. Fidias, T. Lynch, G. Shapiro, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

J. Fujimoto, I. Wistuba, S. Swisher, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

HKI-272, an irreversible pan erbB receptor tyrosine kinase inhibitor: Preliminary phase 1 results in patients with solid tumors.

T. Lynch, H. Burris, P. Munster, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.

J. Temel, T. Lynch, S. Block, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study

T. Lynch, A. Wozniak, Priya Kumar, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A staff dialogue on do not resuscitate orders: psychosocial issues faced by patients, their families, and caregivers.

T. Stern, T. Lynch, B. Chabner, 1999, The oncologist.

Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect.

T. Lynch, E. Krakauer, B. Chabner, 2000, The oncologist.

Burnout: caring for the caregivers.

R. Penson, G. Canellos, C. Picard, 2000, The oncologist.

Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort study.

T. Lynch, A. Wozniak, D. Spigel, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).